BR9912533A - Pharmaceutical composition having improved taste - Google Patents

Pharmaceutical composition having improved taste

Info

Publication number
BR9912533A
BR9912533A BR9912533-1A BR9912533A BR9912533A BR 9912533 A BR9912533 A BR 9912533A BR 9912533 A BR9912533 A BR 9912533A BR 9912533 A BR9912533 A BR 9912533A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
drug
improved taste
improved
taste
Prior art date
Application number
BR9912533-1A
Other languages
Portuguese (pt)
Inventor
Yoshinao Onishi
Hirofumi Doi
Masaaki Odomi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR9912533A publication Critical patent/BR9912533A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA TENDO SABOR MELHORADO". Revela-se uma composição farmacêutica compreendendo uma substância contendo uma droga em que o gosto desagradável da droga é disfarçado, e a um agente de gelação, onde a referida composição farmacêutica é convertida em um preparado com aspecto de gelatina contendo a substância que contém a droga mencionada acima dispersa no mesmo por dissolução em água. A referida composição farmacêutica é reduzida em um gosto desagradável de uma droga tendo um gosto desagradável, tal como amargo, adstringente, ácido, etc. e sua capacidade de deglutição é melhorada."PHARMACEUTICAL COMPOSITION HAVING IMPROVED TASTE". A pharmaceutical composition is disclosed comprising a substance containing a drug in which the unpleasant taste of the drug is disguised, and a gelling agent, where said pharmaceutical composition is converted into a gelatin-like preparation containing the substance containing the drug mentioned above dispersed therein by dissolving in water. Said pharmaceutical composition is reduced in an unpleasant taste of a drug having an unpleasant taste, such as bitter, astringent, acid, etc. and your swallowing ability is improved.

BR9912533-1A 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste BR9912533A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31
PCT/JP1999/004046 WO2000006122A1 (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Publications (1)

Publication Number Publication Date
BR9912533A true BR9912533A (en) 2002-02-13

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912533-1A BR9912533A (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Country Status (10)

Country Link
EP (1) EP1100466A1 (en)
KR (1) KR20010072151A (en)
CN (1) CN1161106C (en)
AR (1) AR019485A1 (en)
AU (1) AU4802699A (en)
BR (1) BR9912533A (en)
CA (1) CA2338996A1 (en)
HK (1) HK1040191A1 (en)
ID (1) ID28910A (en)
WO (1) WO2000006122A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207932A (en) 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Masked Taste Pharmaceutical Compositions
MXPA03008056A (en) 2001-03-05 2004-10-15 Johnson & Johnson Taste masked liquid pharmaceutical compositions.
ATE454906T1 (en) * 2003-07-11 2010-01-15 Astrazeneca Ab SOLID COMPOSITION CONTAINING A PROTON PUMP INHIBITOR
CN100435847C (en) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 Continuing release recipe of containing infusible basic remedy
CN1964699B (en) 2004-06-07 2010-12-08 株式会社吴羽 Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
DE102007026550A1 (en) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudates with improved taste masking
WO2011149814A2 (en) * 2010-05-24 2011-12-01 Amerilab Technologies, Inc. Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
CA2847614C (en) * 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
KR102555664B1 (en) * 2017-02-21 2023-07-18 이에이 파마 가부시키가이샤 granule formulation
FR3101546B1 (en) 2019-10-07 2023-11-10 Roquette Freres Taste masking of isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (en) * 1987-03-13 1987-03-13 Benzon As Alfred ORAL PREPARATION
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
EP0826376B1 (en) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition for oral administration
PT841062E (en) * 1995-07-21 2005-03-31 Daiichi Seiyaku Co PROCESS FOR THE PRODUCTION OF A GRANULAR PREPARATION
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives

Also Published As

Publication number Publication date
EP1100466A1 (en) 2001-05-23
KR20010072151A (en) 2001-07-31
AR019485A1 (en) 2002-02-20
CN1161106C (en) 2004-08-11
CA2338996A1 (en) 2000-02-10
ID28910A (en) 2001-07-12
WO2000006122A1 (en) 2000-02-10
HK1040191A1 (en) 2002-05-31
AU4802699A (en) 2000-02-21
CN1316899A (en) 2001-10-10

Similar Documents

Publication Publication Date Title
NZ501950A (en) Medicinal compositions for application to mucosa
UA42061C2 (en) Oral pharmaceutical composition containing inhibitor of proton pump
DK0696921T3 (en) Veterinary composition containing a proton pump inhibitor
HUP0302114A2 (en) Liquis pharmaceutical composition comprising erythropoietin protein, method for its preparation and its use
DE69928554D1 (en) THERAPEUTIC FORMULATION CONTAINING DOSAGE FORM
BR0009770A (en) Derivatives of indigoid bisindoles capable of penetrating the cell membrane, pharmaceutical formulation and use
DE59802670D1 (en) OSMOTIC DRUG RELEASE SYSTEM
GB9808796D0 (en) Antithrombotic agents
HUP0201877A2 (en) Fast-dispersing dosage forms containing fish gelatin
AR017512A1 (en) TABLETS OF QUICKLY DISPOSABLE METILCELLULOSE FOR ORAL ROUTE ADMINISTRATION AND PROCEDURE TO PREPARE THEM
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
HUP0101411A2 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
ATE243504T1 (en) CEFADROXIL MONOHYDRATE TABLET FORMULATION
HUP0100539A2 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
BR9912533A (en) Pharmaceutical composition having improved taste
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
HUP0201631A2 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
HUP9902135A2 (en) Use of (+)-alfa-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)-ethyl]-4-piperidinemethanol for producing pharmaceutical compositions suitable for treatment depressive disorders and bipolar disorders
HUP0001104A2 (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
HUP9900507A2 (en) Use of levobupivacaine for producing pharmaceutical compositions as an anaesthetic in pregnancy
SE8703632D0 (en) SUSTAINED RELEASE FLUORIDE COMPOSITION
HUP0000125A2 (en) Liquid alendronate formulations and producing them
FR2500303B1 (en)
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1919 DE 16/10/2007.